Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) slipped 0.25% to $69.19 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.76% to 3,981.35 and the Dow Jones Industrial Average rising 1.05% to 33,003.57. Bristol Myers Squibb Co. closed $12.25 short of its 52-week high ($81.44), which the company reached on December 1st.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.08% to $152.45, Pfizer Inc. (PFE) rose 1.10% to $40.62, and Abbott Laboratories (ABT) rose 1.79% to $102.63. Trading volume (6.1 M) remained 2.3 million below its 50-day average volume of 8.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 2, 2023.
(END) Dow Jones Newswires
March 02, 2023 16:41 ET (21:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.